These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 27013159)

  • 21. Late renal artery stenosis after percutaneous renal denervation.
    Lambert T; Blessberger H; Grund M; Steinwender C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
    Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter.
    Honton B; Pathak A; Sauguet A; Fajadet J
    EuroIntervention; 2014; 9(12):1385-8. PubMed ID: 24161437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.
    Courand PY; Pereira H; Del Giudice C; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Vehier C; Lantelme P; Denolle T; Dourmap C; Halimi JM; Girerd X; Rossignol P; Zannad F; Ormezzano O; Vaisse B; Herpin D; Ribstein J; Bouhanick B; Mourad JJ; Ferrari E; Chatellier G; Sapoval M; Azarine A; Azizi M;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model.
    Bertog S; Fischel TA; Vega F; Ghazarossian V; Pathak A; Vaskelyte L; Kent D; Sievert H; Ladich E; Yahagi K; Virmani R
    EuroIntervention; 2017 Feb; 12(15):e1898-e1906. PubMed ID: 27890862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of renal arteries after radio-frequency catheter-based denervation using optical coherence tomography and angiography.
    Roleder T; Skowerski M; Wiecek A; Adamczak M; Czerwienska B; Wanha W; Jadczyk T; Partyka L; Smolka G; Kuczmik W; Ochała A; Dudek D; Tendera M; Gasior Z; Wojakowski W
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):855-62. PubMed ID: 26883432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter.
    Bertog S; Sharma A; Mahfoud F; Pathak A; Schmieder RE; Sievert K; Papademetriou V; Weber MA; Haratani N; Lobo MD; Saxena M; Kandzari DE; Fischell TA; Sievert H
    Cardiovasc Revasc Med; 2021 Mar; 24():77-86. PubMed ID: 32958438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Feasibility of Renal Sympathetic Denervation in Patients With Insufficient Renal Artery Length.
    Pua U; Tang AA; Ooi YW; Ho HH; Ong PJ
    Vasc Endovascular Surg; 2016 Jan; 50(1):63-7. PubMed ID: 26912530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.
    Al Raisi SI; Pouliopoulos J; Qian P; King P; Byth K; Barry MT; Swinnen J; Thiagalingam A; Kovoor P
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E105-E111. PubMed ID: 30549404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location.
    Mahfoud F; Bertog S; Lauder L; Böhm M; Schmid A; Wojakowski W; Parise H; Fischell TA; Kandzari DE; Pathak A; Persu A; Sievert H
    Catheter Cardiovasc Interv; 2021 Nov; 98(6):E832-E838. PubMed ID: 34472656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH; Sayed MM; Reil JC; Lavall D; Ukena C; Linz D; Mahfoud F; Böhm M
    JACC Cardiovasc Interv; 2015 Jun; 8(7):972-80. PubMed ID: 26003031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.
    Vogel B; Kirchberger M; Zeier M; Stoll F; Meder B; Saure D; Andrassy M; Mueller OJ; Hardt S; Schwenger V; Strothmeyer A; Katus HA; Blessing E
    Clin Res Cardiol; 2014 Feb; 103(2):117-24. PubMed ID: 24126436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peregrine system infusion catheter for neurolytic renal denervation in hypertension: an overview of its safety and efficacy.
    Janas A; Wojakowski W
    Expert Rev Med Devices; 2023 Mar; 20(3):179-186. PubMed ID: 36846949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K;
    Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
    Danilov NM; Matchin IuG; Chazova IE
    Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP
    Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?
    Armaganijan L; Staico R; Moraes A; Abizaid A; Moreira D; Amodeo C; Sousa M; Borelli F; Armaganijan D; Sousa JE; Sousa A
    Arq Bras Cardiol; 2014 Apr; 102(4):355-63. PubMed ID: 24652055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.